Ipatasertib (GDC-0068)

Catalog No.S2808 Synonyms: RG7440

Ipatasertib (GDC-0068) Chemical Structure

Molecular Weight(MW): 458

Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.

Size Price Stock Quantity  
In DMSO USD 378 In stock
USD 270 In stock
USD 370 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 8 Publications

3 Customer Reviews

  • Inhibition of AKT signaling abolishes MKK4 phosphorylation on Ser78 in injured axons. Cultures of sensory neurons were treated with 5 µM MK-2206 or 5 µM GDC-0068 for 1 hr prior to axotomy. Axonal proteins harvested at indicated time points after axotomy were subjected to immunoblot analysis.

    Cell, 2015, 160(1-2): 161-76 . Ipatasertib (GDC-0068) purchased from Selleck.

    The functional significance of the PI3K/Akt pathway in CCR5-mediated DNA damage signaling was assessed using the ATP-competitive, small-molecule pan-Akt inhibitor (ipatasertib) and or the CCR5 inhibitor Maraviroc in doxorubicin-treated cells. Western blot analysis was conducted as shown for SUM-159 cells (B) and MDA-MB-175VII (doxorubicin-resistant breast cancer cells) (D).

    Clin Cancer Res, 2018, 78(7):1657-1671. Ipatasertib (GDC-0068) purchased from Selleck.

  • In vitro evaluation of BAR activity in A549-BAR cell line. (A) Bioluminescence activity was quantified 1 hour after treatment in response to various compounds at two concentrations (n = 6). (B) Western blotting analysis after 1 hour of treatment showing the expression of pAKT (Ser473), AKT, pPRAS40 (Thr246), RAS40, pGSK3β (Ser9), GSK3β, pEGFR (Tyr1068), EGFR, and β-Actin of whole cell lysates.

    Neoplasia, 2017, 19(4):310-320. Ipatasertib (GDC-0068) purchased from Selleck.

Purity & Quality Control

Choose Selective Akt Inhibitors

Biological Activity

Description Ipatasertib (GDC-0068) is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM in cell-free assays, 620-fold selectivity over PKA. Phase 2.
Akt1 [1]
(Cell-free assay)
Akt3 [1]
(Cell-free assay)
Akt2 [1]
(Cell-free assay)
5 nM 8 nM 18 nM
In vitro

Testing against a broad panel of 230 kinases, GDC-0068 only inhibits 3 kinases by >70% at 1 μM concentration (PRKG1α, PRKG1β, and p70S6K, with IC50 of 98 nM, 69 nM, and 860 nM, respectively). GDC-0068 displays >100-fold selectivity for Akt over PKA with IC50 of 3.1 μM. In LNCaP, PC3 and BT474M1 cells, GDC-0068 treatment inhibits the phosphorylation of the Akt substrate, PRAS40 with IC50 of 157 nM, 197 nM, and 208 nM, respectively. Furthermore, GDC-0068 selectively inhibits cell cycle progression and viability of cancer cell lines driven by Akt signaling, including those with defects in the tumor suppressor PTEN, oncogenic mutations in PIK3CA, and amplification of HER2, with strongest effects in HER2+ and Luminal subtypes. [1-4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCC70  MWDGeY5kfGmxbjDBd5NigQ>? NVfRVnRFOSEQvF2= NVW3blY5OjRiaB?= NEi1cIpqdmO{ZXHz[ZMhfGinIHHieY5l[W6lZTDv[kBJTVJ|IHHu[EBqdmS3Y3XzJJRp\SCyaH;zdIhwenmuYYTpc44hMGGldHn2ZZRqd25rIH;mJIJwfGhiRVfGVkBidmRiSFXSNy=> NUjFT3JIOjR4NkezO|Y>
MDA-MB-468  NFzidJlHfW6ldHnvckBCe3OjeR?= MUCxJO69VQ>? NVzTZphROjRiaB?= MXjpcoNz\WG|ZYOgeIhmKGGkdX7kZY5k\SCxZjDISXI{ NVf1OJdlOjR4NkezO|Y>
HCC70  MmjkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEWycGMyKM7:TR?= MWq1JIQ> MlPh[Y5p[W6lZYOgeIhmKGGwdHnwdo9tcW[ncnH0bZZmKHKnc4DvcpNm M3\tU|I1PjZ5M{e2
MDA-MB-468  MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXrpbFBFOSEQvF2= NYC4N2M{PSCm M3rsT4VvcGGwY3XzJJRp\SCjboTpdJJwdGmoZYLheIl3\SC{ZYPwc45{\Q>? MViyOFY3PzN5Nh?=
PC-3 M1PKWWZ2dmO2aX;uJGF{e2G7 NIjPdFIxNjByM{itNk42KM7:TR?= NWHnXHN7OSCq M3jxOmROW09? M37sNolv\HWlZYOgZUBld3OnLXTldIVv\GWwdDDpcoNz\WG|ZTDpckBCc3RicHjvd5Bpd3K7bHH0bY9vKGG2IHLveIghXGi{M{C4xsApXDNyODmgZY5lKFOnckS3Ny=> NELQWWMzOzJ6N{W2Ny=>
BT474M1 NImzRWdHfW6ldHnvckBCe3OjeR?= NY\EVJl2OC5yMEO4MVIvPSEQvF2= Ml6wNUBp M3z3fGROW09? Mo\XbY5lfWOnczDhJIRwe2VvZHXw[Y5l\W62IHnuZ5Jm[XOnIHnuJGFsfCCyaH;zdIhwenmuYYTpc44h[XRiYn;0bEBVcHJ|MElCpEhVOzB6KTDhcoQhW2W{NEez NFS1S|UzOzJ6N{W2Ny=>
PC-3 M2flU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGWySZAyNzVxMUCg{txO MV:yOE81QC95MjDo M{nmPWROW09? Mojz[I9{\S2mZYDlcoRmdnSueTDpcoNz\WG|ZYOgeIhmKEdy4pETS|HDqHCqYYPlJJBweHWuYYTpc47DqA>? NYPhUJY{OjN{OEe1OlM>
MCF7-neo/HER2 Moj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M133XFEwPS9zMDFOwG0> MUeyOE81QC95MjDo M1\i[GROW09? NFfLOpBld3OnLXTldIVv\GWwdHz5JIlv[3KnYYPld{B1cGViR{FihLNIOcLicHjhd4UheG:ydXzheIlwdsLi M1v4flI{Ojh5NU[z
BT474M1 M{fUXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXuxM|UwOTBizszN NVXLZ2tJOjRxNEivO|IhcA>? Ml7hSG1UVw>? M1HkNoRwe2VvZHXw[Y5l\W62bImgbY5kemWjc3XzJJRp\SCJMPMAl2cyyqCyaHHz[UBxd3C3bHH0bY9vyqB? M1ftRlI{Ojh5NU[z
PC-3 MUjBdI9xfG:|aYOgRZN{[Xl? MWqxM|UwOTBizszN NWruWoJNOTVxNEivO|IhcA>? M3n0NmROW09? NFHIUWdk[XW|ZYOgZUBld3OnLTDhcoQhfGmvZT3k[ZBmdmSnboSgbY5kemWjc3WgbY4h[XCxcITveIlkKGGwZDDu[YNzd3SrYzDwc5B2dGG2aX;udy=> MmHSNlMzQDd3NkO=
MCF7-neo/HER2 M{nr[WFxd3C2b4Ppd{BCe3OjeR?= MmT5NU82NzFyIN88US=> MXyxOU81QC95MjDo M{nF[mROW09? MV3jZZV{\XNiYTDkc5NmNSCjbnSgeIlu\S2mZYDlcoRmdnRiaX7jdoVie2ViaX6gZZBweHSxdHnjJIFv\CCwZXPyc5Rq[yCyb4D1cIF1cW:wcx?= Mm[2NlMzQDd3NkO=
BT474M1 MXPBdI9xfG:|aYOgRZN{[Xl? NXzSUpNxOS93L{GwJO69VQ>? NUfKVnFEOTVxNEivO|IhcA>? MnjlSG1UVw>? MmfMZ4F2e2W|IHGg[I9{\S1iYX7kJJRqdWVvZHXw[Y5l\W62IHnuZ5Jm[XOnIHnuJIFxd3C2b4TpZ{BidmRibnXjdo91cWNicH;weYxifGmxboO= MmftNlMzQDd3NkO=

... Click to View More Cell Line Experimental Data

In vivo Oral administration of GDC-0068 in PC3 prostate tumor xenografts model induces down-regulation of p-PRAS40. In BT474-Tr xenografts, GDC-0068 treatment reduces pS6 and peIF4G levels, re-localizes FOXO3a to nucleus, and induces feedback upregulation of HER3 and pERK. Administration of GDC-0068 exhibits potent antitumor efficacy in multiple xenograft tumor models, including the PTEN-deficient prostate cancer models LNCaP and PC3, the PIK3CA H1047R mutant breast cancer model KPL-4, and MCF7-neo/HER2 tumor model. [1-4]


Animal Research:[1]
+ Expand
  • Animal Models: Female nude mice bearing LNCaP, PC3, KPL-4, or MCF7 tumor xenografts
  • Formulation: Formulated in 0.5% methylcellulose/0.2% Tween-80
  • Dosages: ~100 mg/kg/day
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 92 mg/mL (200.87 mM)
Ethanol 92 mg/mL (200.87 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 458


CAS No. 1001264-89-6
Storage powder
in solvent
Synonyms RG7440

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT01896531 Active not recruiting Gastric Cancer Genentech Inc. August 31 2013 Phase 2
NCT01896531 Active not recruiting Gastric Cancer Genentech Inc. August 31 2013 Phase 2
NCT01090960 Completed Solid Cancers Genentech Inc. March 2010 Phase 1
NCT01090960 Completed Solid Cancers Genentech Inc. March 2010 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Akt Signaling Pathway Map

Akt Inhibitors with Unique Features

Related Akt Products4

Tags: buy Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) supplier | purchase Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) cost | Ipatasertib (GDC-0068) manufacturer | order Ipatasertib (GDC-0068) | Ipatasertib (GDC-0068) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID